Califf’s New Spin On US FDA Staffing: Attrition Rate Is Too Low

An extremely low attrition rate is not necessarily positive for a scientific organization that benefits from new ways of thinking, US Food and Drug Administration Commissioner Robert Califf argued recently, putting a more positive spin on the agency’s hiring and retention challenges which are often thought of as something like a chronic illness for the FDA.